GREATER CHINA
Double Patenting: A multi-jurisdictional minefield | China, Hong Kong & Southeast Asia
“In China, there is no doctrine preventing an applicant from obtaining multiple patents for obvious variants, patentably indistinct subject matter, or incremental improvements, so long as the claims are...
“In China, there is no doctrine preventing an applicant from obtaining multiple patents for obvious variants, patentably indistinct subject...
Read More
AUSTRALIA
Australia | Lessons from recent interlocutory injunctions in pharmaceutical patent cases 
Is it becoming easier to obtain interlocutory injunctions in Australian pharmaceutical patent cases? We provide an overview of recent decisions in Australia’s Federal Court that shine a light on some key lessons for patent owners.  Overview  In...
Is it becoming easier to obtain interlocutory injunctions in Australian pharmaceutical patent cases? We provide an overview of recent decisions in Australia’s Federal Court that...
Read More
AUSTRALASIA
PCT minimum documentation expands to improve search quality 
On January 1, 2026, new rules came into effect under the Patent Cooperation Treaty (PCT) regarding international patent searches that effectively widens the collection of searchable patent data available to International Searching Authorities, improving access to a...
On January 1, 2026, new rules came into effect under the Patent Cooperation Treaty (PCT) regarding international patent searches that effectively widens the collection of searchable patent...
Read More
SOUTHEAST ASIA
Vietnam | Intellectual Property Law amendments modernise IP framework 
Vietnam has taken another significant step in modernising its IP framework with the latest amendments to its Law on Intellectual Property. These updates streamline procedures, tighten inventorship requirements, and...
Vietnam has taken another significant step in modernising its IP framework with the latest amendments to its Law on...
Read More
AUSTRALIA
2025年版 医薬品特許評論 
この記事は最初に2025年10月2日に英語で公開されました  スプルーソン＆ファーガソンによる、過去1年間におけるオーストラリアの医薬品特許法に関する主要な動向の評論へようこそ。 
この記事は最初に2025年10月2日に英語で公開されました  スプルーソン＆ファーガソンによる、過去1年間におけるオーストラリアの医薬品特許法に関する主要な動向の評論へようこそ。 
Read More
SINGAPORE
シンガポール｜PPHパイロット制度において庁費用の一部返金が可能に
この記事は最初に2025年10月2日に英語で公開されました シンガポール知的財産庁（Intellectual Property Office of Singapore, IPOS）は、企業のPatent Prosecution Highway（PPH）への参入を支援する新たなイニシアティブを発表しました。このパイロット制度では、調査およびまたは審査請求にかかる庁費用について一部返金が可能となります。
この記事は最初に2025年10月2日に英語で公開されました シンガポール知的財産庁（Intellectual Property Office of Singapore, IPOS）は、企業のPatent Prosecution Highway（PPH）への参入を支援する新たなイニシアティブを発表しました。このパイロット制度では、調査およびまたは審査請求にかかる庁費用について一部返金が可能となります。
Read More
AUSTRALIA
Australia | Patents: the evolving law of Support and Sufficiency 
For more than a decade, and for at least another decade to come, Australia’s patent law has openly applied a double-standard with respect to written description requirements, namely the...
For more than a decade, and for at least another decade to come, Australia’s patent law has openly applied...
Read More
AUSTRALIA
Australia | IP tips for critical minerals & cleantech – commercialisation
Next steps: tips for start-ups and early-stage ventures In our previous article, we discussed IP first steps for start-ups and early-stage ventures, especially those that may be encouraged by the...
Next steps: tips for start-ups and early-stage ventures In our previous article, we discussed IP first steps for start-ups and...
Read More